prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SPECIMENS: A. SENTINEL LYMPH NODE#1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. SENTINEL LYMPH NODE #3 LEFT AXILLA. D. SENTINEL LYMPH NODE #4 LEFT AXILLA. E. LEFT BREAST. SPECIMEN(S): A. SENTINEL LYMPH NODE#1 LEFT AXILLA. B. SENTINEL LYMPH NODE #2 LEFT AXILLA. C. SENTINEL LYMPH NODE #3 LEFT AXILLA. D. SENTINEL LYMPH NODE #4 LEFT AXILLA. E. LEFT BREAST. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, Sentinel lymph node #1 left axilla: Negative for tumor. TPB, Sentinel lymph node #2 left axilla: Negative for tumor. TPC, Sentinel lymph node #3 left axilla: Negative for tumor. TPD, Sentinel lymph node #4 left axilla: Negative for tumor. Diagnoses called at. by Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE#1. Received fresh labeled with the patient's identification and designated "Sentinel lymph node number one left axillary". is a fragment of lymphoid tissue measuring 0.5 x 0.4 x 0.3 cm. Touch preparation is performed. The entire specimen. is submitted, A1. B. SENTINEL LYMPH NODE #2. Received fresh labeled with the patient's identification and designated "Sentinel lymph node number two" is a. fragment of lymphoid tissue measuring 0.4 x 0.3 x 0.3 cm. Touch preparation is performed. The entire specimen. is. submitted, B1. C. SENTINEL LYMPH NODE #3. Received fresh labeled with the patient's identification and designated "Sentinel lymph node number three" is a. fragment of lymphoid tissue measuring 1.2 x 0.6 x 0.4 cm. Touch preparation is performed. The entire specimen. is. submitted, C1. D. SENTINEL LYMPH NODE #4. Received in formalin labeled with the patient's identification and designated "sentinel lymph node number four" is a. fragment of lymphoid tissue measuring 1.3 x 1.1 x 0.5 cm. Touch preparation is performed. The entire specimen is. submitted, D1. E. LEFT BREAST SIMPLE MASTECTOMY. Received fresh labeled with the patient's identification and designated "left breast simple mastectomy" is an oriented. (suture in axilla), 304 g, 21 x 14 x 3.5 cm mastectomy specimen with brown tan skin ellipse measuring 8.5 x 3.5 cm,. and 0.5 cm flat nipple. Ink code: Anterior/superior-blue, anterior/inferior-orange, posterior-black. The specimen is. serially sectioned from medial to lateral into 12 slices revealing a mass at the 6 o'clock position, central inferior (slice. 6), measuring 1.2 x 1 x 1 cm, located 0.5-cm from the nearest anterior margin and 1.2-cm from the deep margin. A. second ill-defined firm mass is identified 2-cm from mass number one located in the UOQ, 3 o'clock (slice 7 with. clip), 3 x 2 x 2 cm, located 2-cm from the nearest anterior margin and 2.5-cm from the deep margin. A third mass is. located approximately 1.5-cm from the mass at 3 o'clock measuring 1 x 0.9 x 0.7 cm. The third mass is located in. the upper outer quadrant (one o'clock, slice 7) 1.2-cm from the nearest anterior margin and 2.5-cm from the deep. margin. A portion of the specimen is submitted for tissue procurement. The specimen is representatively submitted: E1-E3: Nipple. E4: Skin. E5-E6: Mass #1, central inferior, 6o'clock, and nearest anterior margin, slice 6. E7: Deep margin, mass #1, slice 6. E8: Tissue in between mass number one and mass number two, slice. 7. E9: Mass #2, upper outer .quadrant, 3 o'clock, slice 7. E10-E11: Mass #2, upper outer quadrant, 3 o'clock, slice 7, E10 with clip. E12: Deep margin over mass #2. E13: Tissue in between mass number two and mass number 3, slice 7. E14-E15: Mass number 3, upper outer quadrant, one o'clock, and nearest anterior margin, slice 7. E16: Possible additional mass #3, slice 8. E17: Deep margin, mass #3. E18: Representative section, LOQ, slice 8. E19: Representative section, UIQ, slice 4. E20: Representative section, LIQ, slice 4. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, LEFT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). B. LYMPH NODE, SENTINEL #2, LEFT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1), SEE NOTE. C. LYMPH NODE, SENTINEL #3, LEFT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. LYMPH NODE, SENTINEL #4, LEFT AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). E. BREAST, LEFT, MASTECTOMY: MULTIPLE FOCI OF INVASIVE DUCTAL CARCINOMA, SBR GRADE 1, LARGEST FOCUS MEASURING 2.1-CM. - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, CRIBRIFORM TYPE WITH CENTRAL. NECROSIS. - SURGICAL RESECTION MARGINS NEGATIVE FOR TUMOR. - BIOPSY SITE CHANGES WITH FIBROSIS. - SEE SYNOPTIC REPORT. NOTE: AE 1/3 negative on SLN#2. SYNOPTIC REPORT - BREAST. Specimen Type: Mastectomy. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: Yes. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 2.1cm. Tumor Site: Upper outer quadrant. Lower outer quadrant. Central. Margins: Negative. Distance from closest margin: 0.2cm. anterior inferior. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 1. Modified Scarff Bloom Richardson Grade: 1. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/4. DCIS present. Margins uninvolved by DCIS. DCIS Quantity: Estimate 2%. DCIS Type: Cribriform. DCIS Location:Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. Location of CA++. Benign epithelium. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by FISH. Performed on Case: Pathological staging (pTN): pT 2N0. CLINICAL HISTORY: Left breast carcinoma with multiple lesions on MRI surrounded primary tumor suspicious of multicentric disease. PRE-OPERATIVE DIAGNOSIS: Left breast carcinoma. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 9. CLINICAL EXPERIENCE: Patients with a recurrence score of: 9 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 6%. ER Score: 10.9 Positive. PR Score: 7.8 Positive. Her2 Score: 10.1 Negative. Interpretation: ER Negative < 6.5 Positive >= 6.5. PR. Negative < 5.5. Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. ) report for further information. Microscopic/Diagnostic Dictation: Pathologist. Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.

expanded version (tokens=2292) : 
 Histological classification: The left breast tumor is classified as invasive ductal carcinoma, NOS, with multifocality and a size of 2.1 cm. Additionally, there multiple foci of ductal carcinoma in situ (DCIS) present. 

Subtype: The subtype of the cancer is LumA.

Necrosis: The DCIS is of the cribriform type with central necrosis.

Tumor Infiltrating Lymphocytes and lymphovascular invasion: None mentioned in the report.

Histological grade, nuclear grade, and Mitotic Score: SBR grade 1 with intermediate nuclear grade, modified Scarff-Bloom-Richardson grade of 1, and mitotic score of 1.

Margins: Surgical resection margins are negative for tumor.

Calcification: There is no mention of calcification in the report.

Receptor status: The tumor is ER-positive and PR-positive. HER2 is negative by FISH.

Ancillary testing results: The recurrence score is 9 determined by Oncotype DX Breast Cancer Assay. The ER Score and the PR score are 10.9 and 7.8 respectively, indicating that both are positive. The Her2 Score is 10.1, which is negative. The pathological staging of the cancer is pT2N0. Pre-operative diagnosis was left breast carcinoma.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2441) : 
 The left breast of a LumA subtype patient had multiple foci of invasive ductal carcinoma and a 2.1 cm size. There was intermediate nuclear grade, DCIS with central necrosis, and no tumor infiltrating lymphocytes or lymphovascular invasion. The tumor was ER-positive and PR-positive, and Her2 negative while recurrence score was 9 determined by Oncotype DX Breast Cancer Assay. The surgical resection margins were clear, and pathological staging determined as pT2N0.

